Author | Michael J. Birrer, MD, PhD, University of Arkansas Medical Center | OncLive

Author | Michael J. Birrer, MD, PhD, University of Arkansas Medical Center

Articles

Dr. Birrer on PARP Inhibitors in Ovarian Cancer

October 25, 2013

Video

Michael Birrer, MD, PhD, professor of medicine, Harvard Medical School, director, Gillette Center for Gynecologic Oncology, Massachusetts General Hospital, discusses the role of PARP inhibitors in ovarian cancer.

Dr. Birrer on the Approval Process in Ovarian Cancer

October 16, 2013

Video

Michael Birrer, MD, PhD, professor of medicine, Harvard Medical School, director, Gillette Center for Gynecologic Oncology, Massachusetts General Hospital, explains how the endpoints of progression-free survival (PFS) and overall survival (OS) are holding back the approval of drugs for patients with ovarian cancer.

Dr. Birrer on the Ovarian Cancer Avastin OS Benefit

March 02, 2012

Video

Dr. Michael Birrer from Massachusetts General Hospital Cancer Center on the Ovarian Cancer Avastin OS Benefit

x